NL7210370A - - Google Patents

Info

Publication number
NL7210370A
NL7210370A NL7210370A NL7210370A NL7210370A NL 7210370 A NL7210370 A NL 7210370A NL 7210370 A NL7210370 A NL 7210370A NL 7210370 A NL7210370 A NL 7210370A NL 7210370 A NL7210370 A NL 7210370A
Authority
NL
Netherlands
Application number
NL7210370A
Other versions
NL151261B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7210370A publication Critical patent/NL7210370A/xx
Publication of NL151261B publication Critical patent/NL151261B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cosmetics (AREA)
NL727210370A 1971-08-05 1972-07-27 Werkwijze voor het bereiden van geneesmiddelen tegen atherosclerose. NL151261B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP46058643A JPS5116430B2 (en:Method) 1971-08-05 1971-08-05

Publications (2)

Publication Number Publication Date
NL7210370A true NL7210370A (en:Method) 1973-02-07
NL151261B NL151261B (nl) 1976-11-15

Family

ID=13090247

Family Applications (2)

Application Number Title Priority Date Filing Date
NL727210370A NL151261B (nl) 1971-08-05 1972-07-27 Werkwijze voor het bereiden van geneesmiddelen tegen atherosclerose.
NL7210369A NL7210369A (en:Method) 1971-08-05 1972-07-27

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL7210369A NL7210369A (en:Method) 1971-08-05 1972-07-27

Country Status (23)

Country Link
US (1) US3864343A (en:Method)
JP (1) JPS5116430B2 (en:Method)
AR (3) AR194123A1 (en:Method)
AT (2) AT320658B (en:Method)
AU (2) AU461281B2 (en:Method)
BE (2) BE787138A (en:Method)
CA (2) CA966489A (en:Method)
CH (2) CH580081A5 (en:Method)
CS (2) CS180587B2 (en:Method)
DE (2) DE2237832A1 (en:Method)
DK (2) DK131857C (en:Method)
ES (2) ES405456A1 (en:Method)
FR (2) FR2150735B1 (en:Method)
GB (2) GB1404367A (en:Method)
HU (2) HU163726B (en:Method)
IE (2) IE36597B1 (en:Method)
LU (2) LU65856A1 (en:Method)
NL (2) NL151261B (en:Method)
NO (1) NO134113C (en:Method)
SE (2) SE408177B (en:Method)
SU (2) SU577986A3 (en:Method)
YU (1) YU35245B (en:Method)
ZA (2) ZA725202B (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR205004A1 (es) * 1973-10-30 1976-03-31 Ishikawa M Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona
NL7702763A (nl) * 1976-03-18 1977-09-20 Takio Shimamoto En Masayuki Is Werkwijze voor de bereiding van thromboxaan- -antagonisten en van preparaten die deze stof- fen bevatten.
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4293553A (en) * 1978-08-11 1981-10-06 Masayuki Ishikawa 1-Phthalazone derivatives, and use thereof
US4861778A (en) * 1986-06-16 1989-08-29 Research Corporation 2,3-dihydrophthalazine-1,4-diones
CH683965A5 (it) * 1993-02-19 1994-06-30 Limad Marketing Exp & Imp Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici.
DE102005011822A1 (de) * 2005-03-15 2006-09-21 Merck Patent Gmbh Phthalazinone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE687916A (en:Method) * 1965-10-12 1967-03-16

Also Published As

Publication number Publication date
SE406587B (sv) 1979-02-19
DK143159B (da) 1981-07-06
CS180587B2 (en) 1978-01-31
FR2150735B1 (en:Method) 1976-04-16
IE36597B1 (en) 1976-12-08
BE787139A (fr) 1972-12-01
BE787138A (fr) 1972-12-01
HU165815B (en:Method) 1974-11-28
DE2238566A1 (de) 1973-02-15
CS180588B2 (en) 1978-01-31
AT317233B (de) 1974-08-26
FR2150736A1 (en:Method) 1973-04-13
AT320658B (de) 1975-02-25
SU513622A3 (ru) 1976-05-05
GB1404367A (en) 1975-08-28
FR2150735A1 (en:Method) 1973-04-13
DE2237832A1 (de) 1973-02-15
ZA725203B (en) 1973-04-25
AU461018B2 (en) 1975-05-15
LU65855A1 (en:Method) 1973-01-15
ZA725202B (en) 1973-04-25
AR197156A1 (es) 1974-03-15
LU65856A1 (en:Method) 1973-01-15
YU201372A (en) 1980-04-30
ES405555A1 (es) 1975-07-01
FR2150736B1 (en:Method) 1976-04-16
HU163726B (en:Method) 1973-10-27
GB1404368A (en) 1975-08-28
DK143159C (da) 1981-11-16
CH580081A5 (en:Method) 1976-09-30
JPS4826781A (en:Method) 1973-04-09
JPS5116430B2 (en:Method) 1976-05-24
DK131857C (da) 1976-02-16
AU4484372A (en) 1974-01-24
AU4494072A (en) 1974-01-31
CH577980A5 (en:Method) 1976-07-30
SE408177B (sv) 1979-05-21
CA966489A (en) 1975-04-22
YU35245B (en) 1980-10-31
IE36598L (en) 1973-02-05
US3864343A (en) 1975-02-04
IE36598B1 (en) 1976-12-08
NO134113C (en:Method) 1976-08-18
IE36597L (en) 1973-02-05
ES405456A1 (es) 1975-07-16
DK131857B (da) 1975-09-15
NL151261B (nl) 1976-11-15
NL7210369A (en:Method) 1973-02-07
CA999236A (en) 1976-11-02
AR197089A1 (es) 1974-03-15
AU461281B2 (en) 1975-05-22
AR194123A1 (es) 1973-06-22
NO134113B (en:Method) 1976-05-10
SU577986A3 (ru) 1977-10-25

Similar Documents

Publication Publication Date Title
DK133606C (en:Method)
DE2113172A1 (en:Method)
DE2232552B2 (en:Method)
CS161959B2 (en:Method)
DE2234841C3 (en:Method)
DE2217870C3 (en:Method)
CS151381B1 (en:Method)
CS148715B1 (en:Method)
CS150426B1 (en:Method)
CS149826B1 (en:Method)
DE2108484A1 (en:Method)
CS165810B1 (en:Method)
CS164351B1 (en:Method)
CS149089B1 (en:Method)
CS152210B1 (en:Method)
CS151659B1 (en:Method)
CH579038A5 (en:Method)
CH595197A5 (en:Method)
CH565726A5 (en:Method)
CH568710A5 (en:Method)
CH568966A5 (en:Method)
CH570433A5 (en:Method)
CH572952A5 (en:Method)
CH574393A5 (en:Method)
CH561745A5 (en:Method)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: INOUE